Recipharm

About:

Recipharm focused on supporting pharmaceutical companies in taking their products from early development to manufacturing.

Website: http://www.recipharm.com

Twitter/X: recipharmab

Top Investors: Swedbank, Svenska Handelsbanken

Description:

Recipharm was established in Sweden in 1995 and has since grown to become a leading Contract Development and Manufacturing Organisation (CDMO). Headquartered in Jordbro, Recipharm employs around 3,500 people and the Recipharm B-share (RECI B) is listed on NASDAQ Stockholm. For over 20 years Recipharm has focussed on supporting pharmaceutical companies in taking their products from early development through to commercial manufacturing. Throughout the entire product lifecycle, Recipharm is there for its clients. Time and time again, Recipharm has delivered innovative solutions. Recipharm has been around for a while and they are proud of the company they have built which is why they want people to know they are here for them today and they will be here for them tomorrow too. That’s the Recipharm way. There are lots of CDMOs in the world. But none quite like Recipharm. Despite the scale and size of their company, they conduct their business in the right way, by respecting all stakeholders at all times and delivering value for money to their clients.